Reticuloendotheliosis_NN
virus_NN
long_JJ
terminal_JJ
repeat_NN
elements_NNS
are_VBP
efficient_JJ
promoters_NNS
in_IN
cells_NNS
of_IN
various_JJ
species_NNS
and_CC
tissue_NN
origin_NN
,_,
including_VBG
human_JJ
lymphoid_JJ
cells_NNS
._.

Promiscuous_JJ
transcriptional_JJ
activity_NN
of_IN
the_DT
reticuloendotheliosis_NN
virus_NN
-LRB-_-LRB-
REV_NN
-RRB-_-RRB-
long_JJ
terminal_JJ
repeat_NN
-LRB-_-LRB-
LTR_NN
-RRB-_-RRB-
was_VBD
detected_VBN
in_IN
transient_JJ
expression_NN
assays_NNS
using_VBG
LTR-chloramphenicol_JJ
acetyltransferase-encoding_JJ
gene_NN
chimeras_NNS
,_,
and_CC
cells_NNS
of_IN
diverse_JJ
species_NNS
and_CC
tissue_NN
type_NN
;_:
levels_NNS
of_IN
expression_NN
from_IN
two_CD
different_JJ
REV_NN
LTRs_NNS
correlate_VBP
with_IN
reports_NNS
of_IN
pathogenicity_NN
of_IN
the_DT
respective_JJ
viruses_NNS
in_FW
vivo_FW
._.

REVs_NNS
do_VBP
not_RB
encode_VB
a_DT
transactivator_NN
targeted_VBN
to_TO
the_DT
viral_JJ
LTR_NN
,_,
and_CC
cells_NNS
infected_VBN
with_IN
Marek_NN
's_POS
disease_NN
virus_NN
,_,
a_DT
herpesvirus_NN
with_IN
an_DT
overlapping_VBG
host_NN
range_NN
,_,
do_VBP
not_RB
express_VB
factors_NNS
that_WDT
preferentially_RB
enhance_VBP
expression_NN
from_IN
REV_NN
or_CC
avian_JJ
sarcoma\/leukemia_NN
virus_NN
LTRs_NNS
._.

REV_NN
LTRs_NNS
work_VBP
efficiently_RB
in_IN
human_JJ
lymphoid_JJ
cells_NNS
,_,
and_CC
are_VBP
viable_JJ
alternatives_NNS
to_TO
promoters_NNS
commonly_RB
used_VBN
for_IN
expression_NN
of_IN
cloned_VBN
genes_NNS
._.

They_PRP
may_MD
also_RB
prove_VB
useful_JJ
in_IN
the_DT
identification_NN
of_IN
new_JJ
,_,
ubiquitous_JJ
cellular_JJ
transcription_NN
factors_NNS
._.

